News

An engineer turned biology researcher co-founded a bio-pharma start-up with the goal of using CRISPR to reverse the mutation causing the degenerative muscle disorder Duchenne muscular dystrophy.

Psilocybin research was "outlawed" in the 70s, but it's back now. It may offer a powerful new tool for treating addictions to substances such as alcohol, cigarettes, and opioids.

Pregnant people with mental health disorders such as depression or bipolar disorder often face an impossible decision: risk their health or their future child's health by discontinuing or continuing their medication.

Researchers redefine cell death in disease and drug discovery.

Ultra-microscopic viruses that selectively target and kill bacteria may mitigate antimicrobial resistance.

A pioneer in reproductive psychiatry, Samantha Meltzer-Brody investigates new therapeutics for depression during and after pregnancy.

Machine learning paired with single-cell analysis helps scientists identify pathways that cause disease and potential therapeutics.

Cardiologist Sheba Meymandi hopes to prevent the deadly cardiac effects of Chagas disease with increased screening and knowledge of the disease.

Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.

By redirecting cells’ endogenous RNA editing machinery, scientists can correct disease-causing mutations, bringing a new kind of gene therapy to the clinic.